COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

被引:124
作者
Landstra, Cyril P. [1 ]
de Koning, Eelco J. P. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Internal Med, Leiden, Netherlands
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
diabetes; COVID-19; SARS-CoV-2; coronavirus; severity; mortality; comorbidities; treatment; INSULIN-SECRETION; SYSTEM INHIBITORS; OXIDATIVE STRESS; TYPE-2; MORTALITY; HYPERGLYCEMIA; CORONAVIRUS; OUTCOMES; PREVALENCE; COMORBIDITIES;
D O I
10.3389/fendo.2021.649525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between COVID-19 and diabetes mellitus is complicated and bidirectional. On the one hand, diabetes mellitus is considered one of the most important risk factors for a severe course of COVID-19. Several factors that are often present in diabetes mellitus are likely to contribute to this risk, such as older age, a proinflammatory and hypercoagulable state, hyperglycemia and underlying comorbidities (hypertension, cardiovascular disease, chronic kidney disease and obesity). On the other hand, a severe COVID-19 infection, and its treatment with steroids, can have a specific negative impact on diabetes itself, leading to worsening of hyperglycemia through increased insulin resistance and reduced beta-cell secretory function. Worsening hyperglycemia can, in turn, adversely affect the course of COVID-19. Although more knowledge gradually surfaces as the pandemic progresses, challenges in understanding the interrelationship between COVID-19 and diabetes remain.
引用
收藏
页数:18
相关论文
共 168 条
  • [1] Obesity as a risk factor for COVID-19: an overview
    Alberca, Ricardo Wesley
    Oliveira, Luana de Mendonca
    Branco, Anna Claudia Calvielli Castelo
    Pereira, Natalli Zanete
    Sato, Maria Notomi
    [J]. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2021, 61 (13) : 2262 - 2276
  • [2] Cytokine secretion in long-standing diabetes mellitus type 1 and 2: Associations with low-grade systemic inflammation
    Alexandraki, Krystallenia I.
    Piperi, Christina
    Ziakas, Panayiotis D.
    Apostolopoulos, Nikolaos V.
    Makrilakis, Konstantinos
    Syriou, Vassiliki
    Diamanti-Kandarakis, Evanthia
    Kaltsas, Gregory
    Kalofoutis, Anastasios
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2008, 28 (04) : 314 - 321
  • [3] Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection
    Allard, Robert
    Leclerc, Pascale
    Tremblay, Claude
    Tannenbaum, Terry-Nan
    [J]. DIABETES CARE, 2010, 33 (07) : 1491 - 1493
  • [6] Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
    Badawi, Alaa
    Ryoo, Seung Gwan
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 49 : 129 - 133
  • [7] Chronic kidney disease in US adults with type 2 diabetes: An updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging
    Bailey R.A.
    Wang Y.
    Zhu V.
    Rupnow M.F.
    [J]. BMC Research Notes, 7 (1)
  • [8] Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
    Barron, Emma
    Bakhai, Chirag
    Kar, Partha
    Weaver, Andy
    Bradley, Dominique
    Ismail, Hassan
    Knighton, Peter
    Holman, Naomi
    Khunti, Kamlesh
    Sattar, Naveed
    Wareham, Nicholas J.
    Young, Bob
    Valabhji, Jonathan
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (10) : 813 - 822
  • [9] Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology
    Bloodworth, Melissa H.
    Rusznak, Mark
    Pfister, Connor C.
    Zhang, Jian
    Bastarache, Lisa
    Calvillo, Sandra Alvarez
    Chappell, James D.
    Boyd, Kelli L.
    Toki, Shinji
    Newcomb, Dawn C.
    Stier, Matthew T.
    Zhou, Weisong
    Goleniewska, Kasia
    Moore, Martin L.
    Hartert, Tina V.
    Niswender, Kevin D.
    Peebles, R. Stokes, Jr.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (02) : 683 - 687
  • [10] Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
    Bode, Bruce
    Garrett, Valerie
    Messler, Jordan
    McFarland, Raymie
    Crowe, Jennifer
    Booth, Robby
    Klonoff, David C.
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (04): : 813 - 821